1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Glaucoma Global Clinical Trials Review, H1, 2015

Glaucoma Global Clinical Trials Review, H1, 2015

  • June 2015
  • -
  • Global Data
  • -
  • 105 pages

Glaucoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Glaucoma Global Clinical Trials Review, H1, 2015" provides an overview of Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Glaucoma Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Glaucoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Glaucoma to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Glaucoma to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Glaucoma 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Glaucoma Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical Trials News on Glaucoma 35
May 11, 2015: Isarna Presents Positive Preclinical Results Supporting Development of ISTH0036 for the Treatment of Glaucoma 35
May 11, 2015: Promising preclinical data on NCX 667 for glaucoma presented at ARVO by Nicox 35
May 11, 2015: Promising preclinical data on NCX 470 for glaucoma presented at ARVO by Nicox 36
Apr 28, 2015: Avalanche Biotechnologies to Present at Upcoming Scientific Meetings 36
Apr 16, 2015: Isarna Initiates First-in-Human Phase I Trial for ISTH0036 to Treat Advanced Glaucoma 37
Mar 24, 2015: Aerie Pharmaceuticals Completes Enrollment in Second Phase 3 Registration Trial of Rhopressa, Novel Triple-Action Product to Lower Intraocular Pressure in Patients with Glaucoma 37
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Novartis AG 39
Clinical Trial Overview of Novartis AG 39
Actavis plc 47
Clinical Trial Overview of Actavis plc 47
Pfizer Inc. 53
Clinical Trial Overview of Pfizer Inc. 53
Santen Pharmaceutical Co., Ltd. 57
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 57
Aerie Pharmaceuticals, Inc. 60
Clinical Trial Overview of Aerie Pharmaceuticals, Inc. 60
Merck and Co., Inc. 62
Clinical Trial Overview of Merck and Co., Inc. 62
Valeant Pharmaceuticals International, Inc. 64
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 64
QLT Inc. 66
Clinical Trial Overview of QLT Inc. 66
Kowa Company, Ltd. 67
Clinical Trial Overview of Kowa Company, Ltd. 67
Mati Therapeutics Inc. 68
Clinical Trial Overview of Mati Therapeutics Inc. 68
Clinical Trial Overview of Top Institutes / Government 69
Aristotle University Of Thessaloniki 69
Clinical Trial Overview of Aristotle University Of Thessaloniki 69
Medical University of Vienna 70
Clinical Trial Overview of Medical University of Vienna 70
Beijing Tongren Hospital 71
Clinical Trial Overview of Beijing Tongren Hospital 71
Shahid Beheshti University of Medical Sciences 72
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 72
Moorfields Eye Hospital NHS Foundation Trust 73
Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust 73
Federal University of Sao Paulo 74
Clinical Trial Overview of Federal University of Sao Paulo 74
Kumamoto University 75
Clinical Trial Overview of Kumamoto University 75
University of Colorado Denver 76
Clinical Trial Overview of University of Colorado Denver 76
Wills Eye Institute 77
Clinical Trial Overview of Wills Eye Institute 77
Chinese University of Hong Kong 78
Clinical Trial Overview of Chinese University of Hong Kong 78
Five Key Clinical Profiles 79
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Disclaimer 105
Source 105

List of Tables
Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Glaucoma Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Glaucoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015* 28
Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31
Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 39
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 47
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 53
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015* 57
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerie Pharmaceuticals, Inc., 2015* 60
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 62
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 64
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015* 66
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015* 67
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mati Therapeutics Inc., 2015* 68
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2015* 69
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 70
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Tongren Hospital, 2015* 71
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 72
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015* 73
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 74
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2015* 75
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2015* 76
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wills Eye Institute, 2015* 77
Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 78

List of Figures
Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Glaucoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31
Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
GlobalData Methodology 104

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
EU5 Ophthalmic Lasers Market Outlook to 2022

EU5 Ophthalmic Lasers Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

EU5 Ophthalmic Lasers Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Ophthalmic Lasers Market Outlook to 2022", provides key market data on the EU5 Ophthalmic Lasers market. The report ...

North America Vitreo Retinal Surgery Devices Market Outlook to 2022

North America Vitreo Retinal Surgery Devices Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

North America Vitreo Retinal Surgery Devices Market Outlook to 2022 Summary GlobalData’s new report, "North America Vitreo Retinal Surgery Devices Market Outlook to 2022", provides key market data on ...

BRIC Ophthalmic Lasers Market Outlook to 2022

BRIC Ophthalmic Lasers Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

BRIC Ophthalmic Lasers Market Outlook to 2022 Summary GlobalData’s new report, "BRIC Ophthalmic Lasers Market Outlook to 2022", provides key market data on the BRIC Ophthalmic Lasers market. The report ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.